Donnerstag, 3. Februar 2011

FDA rejects Orexigen's weight-loss drug Contrave (AFP)

The US Food and Drug Administration on Tuesday declined to approve a weight loss drug by the California pharmaceutical company Orexigen, saying it must conduct more studies to rule out heart risks.(FDA)AFP - The US Food and Drug Administration on Tuesday declined to approve a weight loss drug by the California pharmaceutical company Orexigen, saying it must conduct more studies to rule out heart risks.


Source: http://us.rd.yahoo.com/dailynews/rss/weightloss/*http://news.yahoo.com/s/afp/20110201/ts_alt_afp/healthusobesitypharmacompanyorexigen

cause of mesothelioma mesothelioma patients mesothelioma doctor

Keine Kommentare:

Kommentar veröffentlichen